Which closed-end funds own Bridgebio Pharma Inc?
4 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $12.1M. Security type: debt security. Country: United States. CUSIP 10806XAJ1 · ISIN US10806XAJ19.
Holdings are historical filings (report dates Jun 30, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| GCV Gabelli Convertible & Income Securities Fund | Convertible Securities | 2.08% | $2M | 1,200,000 par | $97.4M | 2.2% discount | Jun 30, 2026 |
| BCV Bancroft Fund | U.S. Equity | 1.98% | $3.8M | 2,250,000 par | $192M | 11.9% discount | Jun 30, 2026 |
| ECF Ellsworth Growth & Income Fund | U.S. Equity | 1.80% | $4.2M | 2,500,000 par | $233M | 10.3% discount | Jun 30, 2026 |
| AVK Advent Convertible & Income Fund | Convertible Securities | 0.27% | $2M | 1,149,000 par | $757M | NAV unavailable | Jul 31, 2026 |
4 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Bridgebio Pharma Inc | common equity | 8 |
| Bridgebio Pharma Inc | debt security | 7 |
| Bridgebio Pharma Inc | debt security | 6 |
| Bridgebio Pharma Inc | debt security | 1 |
Issuer-level search for “BRIDGEBIO PHARMA INC” → · Compare two funds’ portfolios →